HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Transcutaneous measures of oxygen partial pressure and capillaroscopic parameters as affected by naftidrofuryl in patients with obliterative arteriopathies, Fontaine stages II-IV].

Abstract
Transcutaneous partial oxygen pressure on dorsum of foot was determined and capillaroscopy of big toes performed before and after infusions of naftidrofuryl (200 mg/l/h) and of 5% levulose to 30 patients with obliterative arterial disease of lower limbs, stages II to IV (10 patients in each stage). Naftidrofuryl provoked an increase in cutaneous partial oxygen pressure of 26.8 to 36.4 mm Hg (p less than 0.001) whereas no significant change was noted after 5% levulose. In addition, density of visible capillaries increased from 23.5 to 26.1/mm2 with naftidrofuryl. Severe stages of ischemia, evaluated as described by Fagrell, were improved by naftidrofuryl treatment. These findings suggest a favorable action of naftidrofuryl on cutaneous microcirculation distal to arterial obliteration at all Fontaine's stages.
AuthorsJ Ranft, H Heidrich, T Lammersen
JournalJournal des maladies vasculaires (J Mal Vasc) Vol. 12 Issue 1 Pg. 78-81 ( 1987) ISSN: 0398-0499 [Print] France
Vernacular TitleMesures transcutanées de la pression partielle d'oxygène (Tc PO2) et paramètres capillaroscopiques sous naftidrofuryl dans les artériopathies oblitérantes de stade II-IV de Fontaine.
PMID3559415 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Furans
  • Vasodilator Agents
  • Nafronyl
  • Oxygen
Topics
  • Aged
  • Aged, 80 and over
  • Arterial Occlusive Diseases (drug therapy, physiopathology)
  • Capillaries (drug effects)
  • Female
  • Furans (therapeutic use)
  • Humans
  • Leg (blood supply)
  • Male
  • Middle Aged
  • Nafronyl (therapeutic use)
  • Oxygen (blood)
  • Partial Pressure
  • Skin (blood supply)
  • Vasodilator Agents (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: